Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease

Epilepsia

Volumn 43, Issue 10, 2002, Pages 1137-1140

  Kriscenski Perry, Elizabeth ^a   Applegate, Craig D ^a   Serour, Andrew ^a   Mhyre, Timothy R ^a   Leonardo, Christopher C ^a   Pearce, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Batten disease; Cln3; Flurothyl; Neuronal ceroid lipofuscinoses; Seizure induction latencies

Indexed keywords

FLUROTHYL;

ADOLESCENT; AGED; AGING; ANIMAL MODEL; ARTICLE; BODY POSTURE; GENE LOSS; LATENT PERIOD; MALE; MORTALITY; MOUSE; MYOCLONUS SEIZURE; NERVE DEGENERATION; NEURONAL CEROID LIPOFUSCINOSIS; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SEIZURE;

ADMINISTRATION, INHALATION; AGE FACTORS; ANIMALS; DISEASE MODELS, ANIMAL; FLUROTHYL; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, NEUROLOGIC MUTANTS; MOLECULAR CHAPERONES; NEURONAL CEROID-LIPOFUSCINOSES; PHENOTYPE; PROTEINS; SEIZURES;

EID: 0036796221     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.16002.x     Document Type: Article

References (15)

1. Peltonen L, Savukoski M. Vesa J. Genetics of the neuronal ceroid lipofuscinoses. Curr Opin Genet Dev 2000;10:299.
2. Weimer JM, Kriscenski-Perry E, Elshatory Y, et al. The neuronal ceroid lipofuscinoses: mutation in different proteins result in similar disease. NeuroMolec Med 2002;1:111-24.
3. International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell 1995;82:949.
4. Mitchison HM, Bernard DJ, Greene NDE, et al. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. Neurobiol Dis 1999;6:321.
5. Katz ML, Shibuya H, Liu PC, et al. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease). J Neurosci Res 1999;57:551.
6. Boustany RM, Filipek P, Seizures, depression and dementia in teenagers with Batten disease. J Inherit Metab Dis 1993;16:252.
7. Applegate CD, Samoriski GM, Ozduman K. Effects of valprotate, phenytoin and MK-801 in a novel model of epileptogenesis. Epilepsia 1997;38:631.
8. Ferland RJ, Applegate CD. Bidirectional transfer between electrical and flurothyl kindling in mice: evidence for common processes in epileptogenesis. Epilepsia 1999;40:144.
9. Browning RA, Nelson DK. Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transactions. Exp Neurol 1986;93:546.
10. Fuller JL, Sjursen FH Jr. Audiogenic seizures in eleven mouse strains. J Hered 1967:58:135.
11. Ng L, Pedraza PE, Faris JS, et al. Audiogenic seizure susceptibility in thyroid hormone receptor beta-deficient mice. Neuroreport 2001:12:2359.
12. Hengemihle JM, Long JM, Betkey J, et al. Age related psychomotor and spatial learning deficits in 129/SvJ mice. Neurobiol Aging 1999;21:9.
13. Wahlsten D. Corpus callosum varies with strain and supplier of the mice. Brain Res 1982;239:329.
14. Ward R, Trembaly L. Lassonde M. The relationship between callosal variation and lateralization in mice is genotype-dependent. Brain Res 1987;424:84.
15. Wahlsten D, Crabbe JC, Dudek BC. Behavioral testing of standard inbred and 5HT(1B) knockout mice: implication of absent corpus callosum. Behav Brain Res 2001:125:23.